Therapeutic Potential of Stem Cells in Neurodegenerative Diseases

71

[124] M. M. Mahfouz, R. M. Abdelsalam, M. A. Masoud, et al., “The neu-

roprotective effect of mesenchymal stem cells on an experimentally in-

duced model for multiple sclerosis in mice,” Journal of Biochemical and

Molecular Toxicology, vol. 31, p. e21936, 9 2017.

[125] A. Gugliandolo, P. Bramanti, and E. Mazzon, “Mesenchymal stem cells

in multiple sclerosis: Recent evidence from pre-clinical to clinical stud-

ies,” International Journal of Molecular Sciences, vol. 21, p. 8662, 11

2020.

[126] M. Jafarinia, F. Alsahebfosoul, H. Salehi, et al., “Therapeutic effects

of extracellular vesicles from human adipose‐derived mesenchymal stem

cells on chronic experimental autoimmune encephalomyelitis,” Journal

of Cellular Physiology, vol. 235, pp. 8779–8790, 11 2020.

[127] Z. Li, F. Liu, X. He, et al., “Exosomes derived from mesenchymal stem

cells attenuate inflammation and demyelination of the central nervous

system in eae rats by regulating the polarization of microglia,” Interna-

tional Immunopharmacology, vol. 67, pp. 268–280, 2 2019.

[128] F. H. Shamili, M. Alibolandi, H. Rafatpanah, et al., “Immunomodu-

latory properties of msc-derived exosomes armed with high affinity ap-

tamer toward mylein as a platform for reducing multiple sclerosis clinical

score,” Journal of Controlled Release, vol. 299, pp. 149–164, 4 2019.

[129] T. Alexander, R. Greco, and J. A. Snowden, “Hematopoietic stem cell

transplantation for autoimmune disease,” Annual Review of Medicine,

vol. 72, pp. 215–228, 1 2021.

[130] F. Collins, M. Kazmi, and P. A. Muraro, “Progress and prospects for

the use and the understanding of the mode of action of autologous

hematopoietic stem cell transplantation in the treatment of multiple

sclerosis,” Expert Review of Clinical Immunology, vol. 13, pp. 611–622,

6 2017.

[131] M. M. Bakhuraysah, C. Siatskas, and S. Petratos, “Hematopoietic stem

cell transplantation for multiple sclerosis: is it a clinical reality?,” Stem

Cell Research and Therapy, vol. 7, p. 12, 12 2016.

[132] F. Nabizadeh, K. Pirahesh, N. Rafiei, et al., “Autologous hematopoietic

stem-cell transplantation in multiple sclerosis: A systematic review and

meta-analysis,” Neurology and Therapy, vol. 11, pp. 1553–1569, 12 2022.

[133] A. Mariottini, E. D. Matteis, and P. A. Muraro, “Haematopoietic stem

cell transplantation for multiple sclerosis: Current status,” BioDrugs,

vol. 34, pp. 307–325, 6 2020.

[134] K. A. Jellinger, “Understanding depression with amyotrophic lateral

sclerosis: a short assessment of facts and perceptions,” Journal of Neural

Transmission, vol. 131, pp. 107–115, 2 2024.